This study is now closed. Thank you for your interest.
Principal Investigator Name: | Elizabeth Ratchford, M.D. | |
Study Coordinator Name: | Kathleen M. Citro, R.N. | |
Contact Phone: | 410-955-5897 | |
Contact E-mail: | ||
Study Short Title: | CLEVER Trial | |
Study Long Title: | CLaudication: Exercise Versus Endoluminal Revascularization (CLEVER) | |
| IRB Number: | NA_00015857 | |
| Funding Source: | National Institutes of Health / National Heart, Lung, and Blood Institute | |
| Summary of Trial: | CLEVER is a prospective, randomized, multicenter clinical trial designed to determine optimal treatment for claudication due to aortoiliac disease. It compares the benefits of supervised exercise, endovascular revascularization, and optimal medical care. | |
| Inclusions: | Age 40 and older with intermittent claudication due to aortoiliac peripheral arterial disease | |
| Exclusions: | Inability to exercise on a treadmill; allergy to intravenous contrast; other exclusions may apply | |
| Clinical Trial Site: | The Johns Hopkins Hospital, 600 N. Wolfe Street Baltimore, MD 21287; Johns Hopkins at Green Spring Station, 10755 Falls Road, Lutherville, MD 21093 Johns Hopkins Bayview Medical Center, 4940 Eastern Avenue, Baltimore, MD 21224 | |
| Compensation for Participating? | Transportation is reimbursed; subjects randomly assigned to exercise will be compensated for sessions attended. | |
| Start Date: | 5/2008 | |
| Anticipated End Date: | 1/2010 |
Facebook
Twitter
Sharecare
Blogs
YouTube
RSS
Podcasts
